Indeed, FVIII and fibrinogen are acute phase reactants of inflammatory-thrombotic processes which gradually increase with aging in the normal general population along with the development of acquired age-related prothrombotic risk factors such as cancer and autoimmune disorders that enhance the thrombotic risk in these subjects (Favaloro et al., 2014[10]). This evidence concerns the gene F8 and cancer.